Published in Medical Letter on the CDC and FDA, October 9th, 2005
Study 1: Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against Plasmodium vivax in Aotus monkeys.
"Effector mechanisms responsible for providing protective immunity against Plasmodium vivax (Pv) infection were examined in Aotus monkeys vaccinated with two Pv merozoite surface protein-1 (PvMSP-1) recombinant polypeptides that had previously been shown to protect vaccines against parasite challenge," scientists in Colombia report.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.